Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hylenex recombinant in CSII for Type 1 Diabetes
NCT03662334Phase 4Completed
- Sponsor
- Halozyme Therapeutics, Inc.
- Start
- Oct 2013
- Primary completion
- Feb 2014
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of hyaluronidase in type 1 diabetes mellitus (T1D), sponsored by Halozyme Therapeutics, Inc.. Started Oct 2013; status: completed.
02
Drugs
hyaluronidase
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03662334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03662334.